Risks and benefits of medicines: Who do you trust?
2006 Conference
MHRA, in a previous incarnation, was somewhat secretive. That has changed. The views of patients and the public are now a priority. MHRA wants to hear their views and engage in discussion with them.
It commissioned MORI (now Ipsos MORI) to research the views of both the public and healthcare professionals about risk, regulation and communication. The research includes six focus groups of the general public and a quantitative survey of about 2,000 people on the MORI Omnibus Survey.
MHRA and MORI expect to publish the results of the research later this year, after its completion. This paper will present the main findings. It might sketch a chain of trust: patients trust doctors, who trust pharmacists, who trust the regulator.
Authors
Corrado ~ Michele
Michele Corrado is a communications researcher with several years' experience, Michele is Director of Health & Social Research at Ipsos MORI. Her work embraces social and ethical dimensions, risk and trust, and informs policy, communications and planning strategies. She has directed many consultations which have assisted organisations with their strategic thinking.
View all articles by this authorWatkins ~ John
Communications Manager, Medicines and Healthcare products Regulatory Agency (MHRA). John Watkins has had a long and varied career in the Civil Service. He started as a socially-oriented government statistician. He is now in the new Communications Division of MHRA, with responsibilities for public engagement, internal communication and market research. He is developing the listening skills of his organisation.
View all articles by this author« Go back
